GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Fushilai Pharmaceutical Co Ltd (SZSE:301258) » Definitions » Dividend Payout Ratio

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Dividend Payout Ratio : 0.00 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Fushilai Pharmaceutical Co Dividend Payout Ratio?

Suzhou Fushilai Pharmaceutical Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Suzhou Fushilai Pharmaceutical Co Ltd is 0.77, which seems too high.

The historical rank and industry rank for Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

SZSE:301258' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.4   Max: 0.77
Current: 0.77


During the past 11 years, the highest Dividend Payout Ratio of Suzhou Fushilai Pharmaceutical Co was 0.77. The lowest was 0.20. And the median was 0.40.

SZSE:301258's Dividend Payout Ratio is ranked worse than
65.63% of 128 companies
in the Biotechnology industry
Industry Median: 0.435 vs SZSE:301258: 0.77

As of today (2024-05-31), the Dividend Yield % of Suzhou Fushilai Pharmaceutical Co is 1.95%.

During the past 11 years, the highest Trailing Annual Dividend Yield of Suzhou Fushilai Pharmaceutical Co was 2.58%. The lowest was 0.76%. And the median was 1.03%.

Suzhou Fushilai Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Suzhou Fushilai Pharmaceutical Co's average Dividends Per Share Growth Rate was 45.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Suzhou Fushilai Pharmaceutical Co Dividend Payout Ratio Historical Data

The historical data trend for Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Fushilai Pharmaceutical Co Dividend Payout Ratio Chart

Suzhou Fushilai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.20 0.59

Suzhou Fushilai Pharmaceutical Co Quarterly Data
Jun18 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.19 - - -

Competitive Comparison of Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio

For the Biotechnology subindustry, Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio falls into.



Suzhou Fushilai Pharmaceutical Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.58/ 0.98
=0.59

Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.122
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Suzhou Fushilai Pharmaceutical Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Suzhou Fushilai Pharmaceutical Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Business Description

Traded in Other Exchanges
N/A
Address
No. 16, Haiwang Road, New Material Industrial Park, Jiangsu Province, Changshu, CHN, 215500
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in anti-oxidation, anti-aging, and blood sugar improvement.
Executives
Qian Yi Supervisors

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Headlines

No Headlines